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Background: Osteoarthritis (OA) is the most common joint disorder in the world, as it is appears to be prevalent
among 80% of individuals over the age of 75. Although physical activities such as walking have been scientifically
proven to improve physical function and arthritic symptoms, individuals with OA tend to adopt a sedentary
lifestyle. There is therefore a need to improve knowledge translation in order to influence individuals to adopt
effective self-management interventions, such as an adapted walking program.
Methods: A single-blind, randomized control trial was conducted. Subjects (n = 222) were randomized to one of
three knowledge translation groups: 1) Walking and Behavioural intervention (WB) (18 males, 57 females) which
included the supervised community-based aerobic walking program combined with a behavioural intervention and
an educational pamphlet on the benefits of walking; 2) Walking intervention (W) (24 males, 57 females) wherein
participants only received the supervised community-based aerobic walking program intervention and the
educational pamphlet; 3) Self-directed control (C) (32 males, 52 females) wherein participants only received the
educational pamphlet. One-way analyses of variance were used to test for differences in quality of life, adherence,
confidence, and clinical outcomes among the study groups at each 3 month assessment during the 12-month
intervention period and 6-month follow-up period.
Results: The clinical and quality of life outcomes improved among participants in each of the three comparative
groups. However, there were few statistically significant differences observed for quality of life and clinical
outcomes at long-term measurements at 12-months end of intervention and at 6- months post intervention
(18-month follow-up). Outcome results varied among the three groups.
Conclusion: The three groups were equivalent when determining the effectiveness of knowledge uptake and
improvements in quality of life and other clinical outcomes. OA can be managed through the implementation of a
proven effective walking program in existing community-based walking clubs.
Trial registration: Current Controlled Trials IRSCTNO9193542
Keywords: Osteoarthritis, Clinical trial, Walking, Compliance, Adherence, Education, Behavioural intervention,
Guidelines implementation, Knowledge translation* Correspondence: lucie.brosseau@uottawa.ca
1Public Health, specialization in Epidemiology, University Research Chair,
School of Rehabilitation Sciences, University of Ottawa, Ottawa, Canada
Full list of author information is available at the end of the article
© 2012 Brosseau et al.; licensee BioMed Centr
Commons Attribution License (http://creativec
reproduction in any medium, provided the oral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Brosseau et al. BMC Public Health 2012, 12:1073 Page 2 of 15
http://www.biomedcentral.com/1471-2458/12/1073Osteoarthritis (OA) is one of the most disabling degen-
erative diseases affecting the elderly [1]. While the
reported prevalence of knee OA is approximately 3%
among individuals between the ages of 45 to 54 years,
this number rises to 27% for those between 63 and
69 years, and increases once again to 44% for persons
above the age of 80 years [2]. The critical challenge is
to develop physical activity (PA) programs that will en-
courage individuals with OA to not only to initiate, but
also to maintain improvements in exercise behaviour
over a long-term period. This study implemented rela-
tively low-cost community-based walking programs at
existing walking clubs.
The second part of this manuscript examines the effect
of a proven effective walking program based on the
Ottawa Panel CPG [3-5] and implemented through the
use of a multifaceted KT intervention (Part I) [6]. This
portion focuses on the “Outcome evaluation (Clinical
outcomes)” phase of the Knowledge Translation Action
Cycle (KTAC) [7,8] introduced in part I [6].
Background
Physical activity and quality of life
PA can exacerbate age-related decreases in joint health,
functional status, and quality of life (QOL) [9-11]. More-
over, the prolonged physical inactivity observed in indi-
viduals suffering from arthritis increases their risk for
chronic disease such as coronary heart disease, diabetes,
hypertension, obesity and osteoporosis [12,13].
A recent study reported that only 27.8% of individuals
with OA engaged in PA on a regular basis (i.e. 20 minutes
a day, 5 days per week, or 30 minutes per day, 3 days per
week) [13]. Promotion of PA, especially in a community-
based context, is a priority for health organizations
serving the general population [13,14] and is highly
recommended for subgroups affected by chronic diseases
including OA [15-17].
Various PA programs for OA have shown signifi-
cant and beneficial effects on QOL at 2 and 3 months
[18-24]. However, this effect was not maintained after
a period of unsupervised PA [20,21,25]. According to
Hurley [26], “exercise benefits people with OA while
people are exercising; when they stop exercising the
benefits can be maintained for a short time, but the
gains are likely to be lost overtime unless individuals are
actively encouraged to continue exercising”.
Behavioural interventions
Behavioural interventions have been used with other
chronic conditions to improve long-term maintenance
of PA regimens with varying success. Patient education,
health counselling, goal setting, telephone contacts, ex-
ercise logs, social/peer support and positive feedback ei-
ther alone or in various combinations, have been studiedin cardiovascular disease [27-30] and rheumatoid arth-
ritis [31]. As with OA, multifaceted approaches appear
to have the greatest impact on long-term adherence, de-
gree of PA performed, and QOL.
The purpose of this randomized controlled trial (RCT)
was to compare 1) improvements in quality of life
(QOL) (primary outcome) and clinical outcomes such as
pain, mobility and endurance; 2) adherence rates; and 3)
confidence and self-efficacy after the implementation of
a 12-month supervised community-based aerobic walk-
ing program (SCAWP) based on the Ottawa Panel clin-
ical practice guidelines (CPG) [3-5] among three
knowledge translation (KT) intervention arms. QOL,
confidence, and self-efficacy were compared at 12-
months (end of treatment) and at 18-months (6-months
post-intervention). Adherence was compared during the
intervention period at 3, 6, 9 and 12- months. Adher-
ence, confidence and self-efficacy results are presented
in part I of this manuscript.
Methods
Design
A single blind randomized controlled trail was used for
this study. The hypothesis of this study was that a super-
vised community-based walking program would have a
positive impact on participants with mild to moderate
OA of the knee, if they walked regularly as stated in the
recommendations of the Ottawa Panel [3-5]. This
community-based study was approved by the University
of Ottawa Research Ethics Board as well as by the City
of Ottawa Public Health Research Ethics Board. All par-
ticipants signed informed consent. Please see part I for
more details on the study design [6].
Sample and recruitment
A total of 222 adults with mild to moderate OA of the
knee were recruited from Ottawa, Ontario and Gatineau,
Québec, Canada. Please see part I for inclusion/exclu-
sion criteria [6].
Intervention
Participants were randomly assigned to one of the three
KT intervention groups using central randomization
[32] and computer generated numbers [33]: 1) Walking
and Behavioural intervention (WB) ( implementation
strategy) (18 males, 57 females) which included the
SCAWP with a behavioural intervention and an educa-
tional pamphlet on the benefits of walking; 2) Walking
intervention (W) (implementation strategy) (24 males,
57 females) wherein participants only received the
SCAWP intervention and the educational pamphlet; 3)
Self-directed control (C) (dissemination strategy) (32
males, 52 females) wherein participants only received
the educational pamphlet. All 3 groups were provided
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measure physical performance and additional PA aside
from the walking sessions. The KT and dissemination
strategies were implemented over a 12-month duration
and participants were assessed for additional 6 months
(15 and 18-month assessments). A detailed description
of each intervention can be found in part I of this
manuscript.Data collection
Participants were assessed by an independent evaluator
at baseline and at each 3 month interval (months 3, 6, 9,
12) during the intervention period. Participants were
then assessed at 3 and 6 months post-intervention dur-
ing the follow-up period (months 15 and 18). Partici-
pants were asked to complete a collection of validated
questionnaires as well as perform physical tests as each
assessment.Clinical outcome measures
Health-related quality of life
The Arthritis Impact Measurement Scale (AIMS2) and
the Short Form (SF-36) questionnaires were adminis-
tered during patient evaluations. The scientific literature
in rheumatology recommends that researchers use the
AIMS2 and SF-36 concurrently, as they complement
one another [34-36]. In support of their complementary
roles, the detection of clinically important changes is
enhanced through the use of a disease specific instru-
ment (AIMS2), while a generic measure (SF-36) properly
distinguishes different levels of self-reported general
health statuses and co-morbidities not necessarily related
to OA.
The SF-36 is the most widely used and extensive-
ly validated generic measure of health-related QOL
[36-38]. The SF-36, which consists of 8 subscales and 36
questions, is a reliable and valid scale for several medical
conditions, including rheumatic diseases [35,36,39-41].
Internal consistency via Cronbach’s alpha ranged be-
tween 0.74 to 0.96 over the different sections [40]. Test-
retest intra-class correlation coefficients range from
0.75 to 0.93 [41]. Validity testing revealed that the SF-36
correlates moderately with several other measures related
to disease activity, pain, depression and QOL [36,41].
The SF-36 was used to report QOL in several RCTs in-
volving various PA programs designed for individuals
with OA [19,21,24]. The responsiveness of this instru-
ment was demonstrated in these studies by appropriate
and expected changes in mean scores according to age,
sex, marital status, severity of OA, and presence or ab-
sence of co morbid conditions. Mean scores also changed
appropriately over time in response to the interventions.
The aggregated SF-36 components are scored in whichhigher scores represented better health-related quality of
life [42].
The Arthritis Impact Measurement Scale (AIMS2) is a
disease-specific QOL scale [36] that consists of 101
items and includes various subscale scores [42]. The
AIMS2 walking and bending sub-scale was considered
as the primary outcome. All other AIMS2 sub-scales
were used as secondary outcomes, since the use of the
global scale could not be aggregated. The global AIMS2
scales are scored in which a low value indicated a higher
health status [43,44].This QOL instrument has been
used in several walking program studies that included
subjects with OA [18,22,45]. AIMS2 has been shown to
possess good internal consistency (alpha coefficients ran-
ging from 0.72 to 0.91) and good test-retest results
(Intraclass correlation coefficients ranging from 0.78 to
0.94). The construct and criterion validity have also been
examined. Standardized response means for changes in
AIMS2 scores over 3 months ranged from 0.36 to 0.80
[36,44].
Functional status was measured using the Western
Ontario and McMaster Universities Osteoarthritis Index
(WOMAC) (Bellamy and Buchanan, 1986). WOMAC is
a self-administered multidimensional index containing
dimensions for pain, stiffness and function. This five-
point instrument has been shown to be valid and reliable
in individuals with hip or knee rheumatic conditions,
and is sensitive to change over time. The WOMAC
questionnaire [45] has been adapted for lower extremity
joints affected with OA, such as the knee or hip
[19,22,45-48]. WOMAC is widely used and has been ex-
tensively validated [49,50]. Furthermore, according to
Rogers & Irrgang [50], the WOMAC pain and functional
subscales exhibit excellent responsiveness. The minimal
clinically important rehabilitation effects ranged from
0.80 to 1.01 [51].
Other quantitative functional outcomes such as
walking endurance and gait speed [20,22,52-55] were
measured using the 6-minute walk test [55] and Timed-
up-and-Go test [56].
Level of physical activity
Changes in level of PA were measured using the Seven
Day Physical Activity Recall (7-day PAR) [57-59].
The 7-day PAR is a validated instrument in a calendar
format in which a participant can indicate the duration
(minutes per day), frequency (days per week) and intensity
(multiples of basal metabolic rate). An adapted version of
the 7-day PAR was included in the logbooks where PA was
split into distinct walking and other physical activities.
Analysis
A repeated measure mixed model was used to assess the
change in health-related QOL measures (adjusted
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clinical outcomes from baseline to 12 months (end of
intervention) and to 18 months (6 month follow-up
post-intervention) among three study groups. The model
included variables such as intervention group, study
month, and an interaction term between the interven-
tion group and study month. Missing data was assumed
to be missing at random (MAR) in order to include in-
complete data. Pair wise differences comparing each
group to one another (W vs. C, W vs. WB, WB vs. C)
were assessed. The repeated measure mixed model was
used to compare the change of outcomes from baseline
to the 18-month follow-up. Statistical analyses were per-
formed using SAS (version 9.2, SAS Institute Inc., Cary,
North Carolina), and statistical significance was defined




Short-Form 36 There were no statistically significant
results between the three groups for QOL measured
with the SF-36 (Table 1) with the exceptions of the vari-
ables “physical role functioning”, “physical role”, “pain
index” and “standardized physical component”. At 12-
months, results favoured the W group for the “physical
role” variable when compared to the WB group (p =
0.04). At 18-months, results favoured the W group
for the “physical functioning” (p = 0.02) and “pain index”
(p = 0.00) variables when compared to the WB group.
The self-directed group was also favoured when com-
pared either to the W or WB groups for the “physical
functioning” (p = 0.01), “pain index” (p = 0.03) and “stan-
dardized physical component” (p = 0.00) variables.
The selected results for SF-36 analysis were presented
at baseline, at end of intervention (12 months), and at 6-
months post intervention (18- month follow-up). The
mean values of the 8 domains of the SF-36 for the three
study groups are detailed in Table 1. After the 12-month
intervention phase of the walking program, the self-
directed group (C) had the highest mean (± SE)
“physical role” score 65.85(±42.48 ). The WB group
demonstrated the lowest mean pain index score 63.80
(±20.12). At 18-months, the self-directed group (C)
demonstrated the highest mean scores for “physical
functioning” 75.69(±19.65), “pain index” 67.44(±18.32),
and “ standardized physical component” 45.15(±8.93).
The WB group had the lowest mean scores for “physical
functioning” 63.25(±25.71), “pain index” 61.17(±18.32),
and “ standardized physical component” 40.91(±11.04).
Arthritis Impact Measurement Scale 2 (AIMS2) The
AIMS2 analyses were performed at baseline, at end of
intervention (12- months), and at 6-months postintervention (18- month follow-up) (Table 2). At 12-
months, statistical significance was observed when the
WB group was compared to the self-directed group (C),
mean results (± SE) favoured the self-directed group (C)
for the “hand and finger” (p = 0.04), “social activity”
(p = 0.01), “arthritis pain” (p = 0.02), “symptoms com-
ponent” (p = 0.02)and “social interaction component”
(p = 0.01) variables. At 12-months, statistical signifi-
cance was only observed when the W group was com-
pared to the self-directed group (C), mean results (± SE)
favoured the self-directed group (C) for the “social activity”
(p = 0.01) variable.
At 18- months, when the WB group was compared to
the self-directed group (C), mean results (± SE) favoured
the self-directed group for the “walking and bending”
(p = 0.044), “household tasks” (p = 0.02), “arthritis
pain” (p = 0.03), “physical component” (p = 0.01), and
“symptoms component” (p = 0.03) variables. When the W
group was compared to the WB group, results favoured
the W group for the “arthritis pain” (p = 0. 01), “arthritis
impact” (p = 0. 01), “physical component” (p = 0.04), and
“symptoms component” (p = 0. 01) variables.
At 12-months, the WB group demonstrated the
highest mean scores for the “arthritis pain” 3.79
(±2.29) and “symptoms component” 3.79 (±2.29)
variables, and the lowest score 0.46 (±0.69) for the
“hand and finger” variable. The W group had the
highest mean scores for the “social activity” 4.73
(±1.57) and “social interaction component” 3.36
(±1.51) variables. The self-directed group (C) had
the lowest “symptoms component” score 3.94
(±2.38). At 18-months, the WB group demonstrated
the highest mean scores for the “walking and bend-
ing” 3.70(±2.40), “household tasks” 0.57(±1.38),
“arthritis pain” 3.64(±2.16), “physical component”
1.06(±0.75), and “symptoms component” 3.64(±2.16)
variables. The self-directed group(C) had the lowest
scores for the “walking and bending” 2.708(±2.11),
“arthritis pain” 3.40(±2.23), “physical component”




At 12 and 18- months, improvements were observed in
each three comparative groups as the overall item scores
decreased when compared to baseline (Table 3). No statis-
tical significance was demonstrated for total WOMAC
scores at 12-months. At 18 months, the self-directed (C)
group demonstrated the lowest mean (± SD) “pain” scores
23.50 (±17.78). The only statistically significant difference
in total functional scores found between the 3 groups was
at 18-months which favoured the W group when compared
to the WB group (±16.74).
Table 1 Summary of SF-36 for three study arms
Variables Baseline 12 Months 18 Months
W WB C W WB C W WB C
N N N N N N N N N
Mean ± SD Mean ± SD Mean ± SD Mean ± SD Mean ± SD Mean ± SD Mean ± Sd Mean ± SD Mean ± SD
W Vs. C(P) WB Vs. C(P) WB Vs. W(P) W Vs. C(P) WB Vs. C(P) WB Vs. W(P)
Physical Functioning 79 69 74 44 43 41 44 42 36
63.003 ± 18.332 66.449 ± 19.157 67.275 ± 20.446 70.088 ± 18.819 68.127 ± 19.694 68.171 ± 26.381 68.157 ± 21.308 63.254 ± 25.705 75.694 ± 19.645
(0.250) (0.982) (0.234) (0.836) *(0.012) *(0.015)
Role Physical 78 69 74 44 44 41 44 42 36
52.350 ± 40.064 69.203 ± 35.393 56.757 ± 39.755 61.742 ± 39.755 59.659 ± 41.138 65.854 ± 42.484 57.386 ± 40.556 60.119 ± 40.971 68.519 ± 39.345
(0.909) (0.063) *(0.044) (0.864) (0.058) (0.071)
Pain Index 78 69 74 44 44 41 44 42 36
60.487 ± 16.040 67.348 ± 18.261 62.149 ± 18.762 63.818 ± 19.134 63.795 ± 20.124 67.805 ± 18.378 65.045 ± 18.881 61.167 ± 18.322 67.444 ± 18.315
(0.581) *(0.026) (0.082) (0.491) *(0.030) *(0.003)
General Health Perceptions 79 68 74 44 44 41 44 42 36
67.873 ± 18.214 70.838 ± 20.465 70.635 ± 17.434 67.619 ± 17.484 68.926 ± 19.008 72.000 ± 18.358 69.307 ± 19.189 66.143 ± 20.483 69.917 ± 18.243
(0.223) (0.089) (0.605) (0.226) (0.496) (0.051)
Vitality 79 68 74 44 44 41 44 42 36
58.481 ± 17.711 60.588 ± 21.152 60.473 ± 18.984 62.045 ± 19.628 60.341 ± 19.778 64.756 ± 18.267 60.152 ± 21.858 58.929 ± 18.791 66.157 ± 17.839
(0.856) (0.475) (0.359) (0.845) (0.517) (0.380)
Social Functioning 79 69 74 44 44 41 44 42 36
80.380 ± 22.080 85.507 ± 18.394 82.432 ± 20.474 79.545 ± 22.889 84.375 ± 18.309 85.671 ± 20.264 78.125 ± 26.704 84.226 ± 19.533 79.167 ± 21.547
(0.266) (0.168) (0.775) (0.232) (0.735) (0.379)
Role Emotional 78 69 74 44 44 41 44 42 36
75.214 ± 37.000 84.058 ± 29.488 74.324 ± 37.643 85.606 ± 30.835 81.061 ± 32.468 82.927 ± 35.057 75.000 ± 40.106 80.159 ± 31.286 82.407 ± 33.320
(0.949) (0.170) (0.144) (0.597) (0.290) (0.574)
Mental Health Index 78 68 74 44 44 41 44 42 36
76.500 ± 17.558 77.588 ± 15.670 80.365 ± 13.974 78.364 ± 16.007 80.000 ± 14.823 81.366 ± 14.411 77.114 ± 17.926 77.405 ± 15.759 79.333 ± 14.890
(0.735) (0.909) (0.822) (0.597) (0.880) (0.486)
Health Transition Item 79 69 74 43 43 41 44 42 36 2.639 ± 0.899
2.975 ± 0.987 3.014 ± 0.737 2.959 ± 0.818 2.419 ± 0.852 2.698 ± 0.914 2.463 ± 0.840 2.727 ± 0.924 3.024 ± 1.024 (0.459)



















Table 1 Summary of SF-36 for three study arms (Continued)
Standardized Physical Component 77 68 74 44 43 41 44 42 36
40.516 ± 8.598 43.645 ± 8.656 41.996 ± 9.100 42.508 ± 9.229 42.192 ± 10.066 43.464 ± 9.409 42.820 ± 9.240 40.909 ± 11.038 45.149 ± 8.930
(0.804) (0.135) (0.074) (0.703) *(0.009) *(0.002)
Standardized Mental Component 77 68 74 44 43 41 44 42 36
52.914 ± 10.845 53.812 ± 8.639 53.556 ± 8.995 53.819 ± 9.852 54.476 ± 7.329 55.162 ± 8.540 51.993 ± 11.000 53.922 ± 9.023 53.101 ± 9.914



















Table 2 Summary of AIMS2 for three study arms
Variables Baseline 12 Months 18 Months
W WB C W WB C W WB C
N N N N N N N N N
Mean ± SD Mean ± SD Mean ± SD Mean ± SD Mean ± SD Mean ± SD Mean ± Sd Mean ± SD Mean ± SD
W Vs. C(P) WB Vs. C(P) WB Vs. W(P) W Vs. C(P) WB Vs. C(P) WB Vs. W(P)
Mobility 79 69 74 44 44 41 44 42 36
1.281 ± 1.511 1.058 ± 1.621 1.169 ± 1.479 0.614 ± 1.017 0.773 ± 0.866 0.720 ± 1.090 0.815 ± 1.189 0.869 ± 1.215 0.486 ± 0.898
(0.662) (0.276) (0.121) (0.714) (0.086) (0.156)
Walking
and Bending
79 69 74 44 44 41 44 42 36
4.044 ± 2.047 3.513 ± 2.538 3.792 ± 2.494 3.364 ± 2.216 3.695 ± 2.248 3.085 ± 2.490 3.670 ± 2.323 3.702 ± 2.402 2.708 ± 2.112
(0.900) (0.081) (0.094) (0.656) *(0.044) (0.099)
Hand and
Finger
79 68 74 44 44 41 44 42 36
0.704 ± 1.061 0.647 ± 1.033 0.412 ± 0.904 0.602 ± 0.931 0.455 ± 0.689 0.744 ± 1.937 0.616 ± 1.195 0.693 ± 0.917 0.569 ± 1.196
(0.127) *(0.039) (0.573) (0.314) (0.552) (0.678)
Arm Function 79 68 74 44 44 41 43 42 36
0.363 ± 0.795 0.368 ± 1.010 0.264 ± 0.642 0.295 ± 0.726 0.591 ± 1.448 0.220 ± 0.699 0.581 ± 1.170 0.405 ± 0.843 0.194 ± 0.511
(0.451) (0.253) (0.673) (0.175) (0.635) (0.369)
Self Care 79 69 74 44 44 41 43 42 36
0.391 ± 1.632 0.045 ± 0.247 0.194 ± 1.179 0.114 ± 0.509 0.028 ± 0.132 0.091 ± 0.358 0.087 ± 0.572 0.104 ± 0.435 0.000 ± 0.000
(0.801) (0.726) (0.541) (0.541) (0.409) (0.147)
Household
Tasks
79 69 74 44 44 41 44 42 36
0.539 ± 1.093 0.272 ± 0.806 0.450 ± 1.549 0.341 ± 1.004 0.114 ± 0.279 0.274 ± 0.713 0.412 ± 0.933 0.565 ± 1.379 0.122 ± 0.468
(0.924) (0.879) (0.802) (0.679) *(0.024) (0.053)
Social Activity 79 69 74 44 43 41 44 42 36
4.530 ± 1.723 4.449 ± 1.774 4.639 ± 2.050 4.727 ± 1.573 4.453 ± 1.886 3.732 ± 2.188 4.625 ± 1.840 4.720 ± 1.860 4.281 ± 2.141
*(0.013) *(0.006) (0.767) (0.944) (0.233) (0.187)
Support
From Family
79 69 74 44 43 40 44 42 36
1.907 ± 2.286 1.778 ± 1.938 2.204 ± 2.158 1.989 ± 2.269 2.253 ± 2.379 2.328 ± 2.356 1.932 ± 2.437 1.979 ± 2.052 2.743 ± 2.606
(0.605) (0.100) (0.237) (0.308) (0.824) (0.414)
Arthritis Pain 79 69 73 44 44 41 44 3. 42 35
4.396 ± 1.907 3.813 ± 2.175 4.270 ± 2.426 3.494 ± 2.383 3.793 ± 2.285 3.494 ± 2.383 440 ± 2.409 3.642 ± 2.157 3.400 ± 2.228
(0.523) *(0.019) (0.075) (0.836) *(0.030) *(0.013)
Work 37 25 40 15 11 18 12 9 14
2.095 ± 2.302 1.975 ± 2.193 1.828 ± 1.958 1.542 ± 1.828 0.625 ± 0.791 1.875 ± 1.561 2.188 ± 2.450 2.083 ± 1.849 1.830 ± 1.826
(0.536) (0.171) (0.428) (0.730) (0.825) (0.608)
Level of Tension 79 69 74 44 43 40 44 42 36
3.327 ± 1.850 3.338 ± 1.900 3.030 ± 1.718 3.085 ± 1.692 3.078 ± 1.731 2.972 ± 1.897 3.313 ± 1.969 3.012 ± 1.799 2.815 ± 1.601
(0.728) (0.810) (0.916) (0.804) (0.825) (0.628)
Mood 79 69 74 44 42 40 44 42 36
2.036 ± 1.548 1.937 ± 1.479 1.726 ± 1.168 1.795 ± 1.636 1.818 ± 1.324 1.478 ± 1.278 1.795 ± 1.909 1.893 ± 1.290 1.531 ± 1.301
(0.686) (0.224) (0.397) (0.622) (0.449) (0.194)
Satisfaction 79 69 74 43 44 41 44 42 36
2.567 ± 1.580 2.746 ± 1.762 2.523 ± 1.458 2.113 ± 1.818 2.333 ± 1.728 2.127 ± 1.640 2.183 ± 2.080 2.657 ± 1.885 1.934 ± 1.570
(0.529) (0.800) (0.704) (0.599) (0.305) (0.108)
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Table 2 Summary of AIMS2 for three study arms (Continued)
Health
Perception
79 68 72 44 43 39 42 42 34
3.890 ± 2.417 3.340 ± 2.159 3.572 ± 2.464 3.644 ± 2.369 3.495 ± 1.778 3.340 ± 1.877 3.340 ± 1.952 3.658 ± 2.310 3.438 ± 1.926
(0.420) (0.117) (0.418) (0.311) (0.473) (0.073)
Arthritis Impact 76 65 70 39 40 36 34 39 30
3.191 ± 2.757 2.769 ± 2.259 2.929 ± 2.407 2.372 ± 1.809 2.500 ± 2.334 2.222 ± 1.962 1.985 ± 2.112 3.013 ± 2.512 2.250 ± 1.897
(0.431) (0.077) (0.308) (0.317) (0.140) *(0.011)
Physical
Component
79 68 74 44 44 41 43 42 36
1.224 ± 0.830 0.991 ± 0.777 1.047 ± 0.747 0.883 ± 0.845 0.943 ± 0.549 0.856 ± 0.771 1.039 ± 1.005 1.057 ± 0.753 0.676 ± 0.612
(0.554) (0.352) (0.121) (0.562) *(0.011) *(0.040)
Affect
Component
79 69 74 44 42 40 44 42 36
2.681 ± 1.570 2.637 ± 1.505 2.378 ± 1.344 2.440 ± 1.502 2.438 ± 1.436 2.225 ± 1.445 2.554 ± 1.806 2.452 ± 1.423 2.173 ± 1.368
(0.937) (0.690) (0.623) (0.934) (0.835) (0.762)
Symptoms
Component
79 69 73 44 44 41 44 42 35
4.372 ± 1.907 3.813 ± 2.175 4.270 ± 2.426 3.523 ± 2.360 3.793 ± 2.285 3.494 ± 2.383 3.440 ± 2.409 3.642 ± 2.157 3.400 ± 2.228
(0.523) *(0.019) (0.075) (0.836) *(0.030) *(0.013)
Social Interaction
Component
79 69 74 44 43 40 44 42 36
3.241 ± 1.578 3.114 ± 1.552 3.421 ± 1.614 3.358 ± 1.506 3.353 ± 1.698 3.033 ± 1.977 3.278 ± 1.906 3.350 ± 1.556 3.512 ± 1.965
(0.081) *(0.006) (0.268) (0.388) (0.539) (0.127)
Role Component 37 25 40 15 11 18 12 9 14
2.095 ± 2.302 1.975 ± 2.193 1.828 ± 1.958 1.542 ± 1.828 0.625 ± 0.791 1.875 ± 1.561 2.188 ± 2.450 2.083 ± 1.849 1.830 ± 1.826
(0.536) (0.171) (0.428) (0.730) (0.825) (0.608)
Table 3 Summary of WOMAC for three study arms
Variables Baseline 12 Months 18 Months
W WB C W WB C W WB C
N N N N N N N N N
Mean ± SD Mean ± SD Mean ± SD Mean ± SD Mean ± SD Mean ± SD Mean ± SD Mean ± SD Mean ± SD
W Vs. C(P) WB Vs. C(P) WB Vs. W(P) W Vs. C(P) WB Vs. C(P) WB Vs. W(P)
Pain 79 69 73 43 42 41 43 42 35
31.15 ± 14.29 26.81 ± 14.92 30.30 ± 16.47 24.65 ± 15.78 25.32 ± 15.98 25.00 ± 19.44 23.60 ± 15.09 26.16 ± 17.97 23.50 ± 17.78
(0.572) (0.238) (0.522) (0.863) (0.157) (0.096)
Stiffness 79 69 71 44 41 40 43 42 35
38.90 ± 18.01 36.41 ± 18.90 39.08 ± 19.81 30.96 ± 22.31 30.79 ± 19.58 28.43 ± 20.41 29.94 ± 20.43 31.40 ± 20.75 27.14 ± 18.80
(0.125) (0.405) (0.486) (0.494) (0.423) (0.890)
Physical
Function
79 68 72 44 38 40 43 42 35
28.16 ± 15.41 27.65 ± 18.22 26.89 ± 16.34 24.48 ± 13.79 25.27 ± 15.70 25.06 ± 13.53 18.20 ± 14.63 24.15 ± 17.24 19.40 ± 17.08
(0.672) (0.903) (0.763) (0.582) (0.381) (0.140)
Total
WOMAC Score
79 68 70 43 41 40 43 42 35
29.70 ± 14.09 28.27 ± 16.42 28.95 ± 15.28 21.05 ± 13.62 23.60 ± 13.61 22.32 ± 17.77 20.30 ± 13.97 25.58 ± 16.60 20.90 ± 16.74
(0.612) (0.475) (0.821) (0.464) (0.129) *(0.019)
W: Walking only group; WB: Walking and Behavioural Group; C: Self-directed group (unsupervised/self-directed); N: number of subjects in each comparative group;
SD: standard deviation; vs: versus; data is presented as mean (standard deviation); P: p-value (statistical significance); * Statistically significant; WOMAC: Western
Ontario MacMaster Osteoarthritis Index.
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There were no statistically significant results for the 6-min
walk test among the three groups after 12 and 18- months
(Table 4). Distance (in meters) increased during the
6- minute walk test at both 12 and 18 months when
compared to baseline among all three groups (Table 5). At
12- months, individuals in the W group had the highest
score 524.86 (±106.52). The self-directed (C) group had the
highest score 540.35 (±103.37) at 18 months.
Gait speed
There were no statistically significant results at both
12 months and 18-months for gait speed (Table 5).
These results were similar to walking endurance, as
gait speed was calculated using the 6 minute walk test.
At 12 months, the W group had the highest score
1.458(±0.296). At 18-months the self-directed (C) group
had the highest score 1.501 (±0.287).
Timed up and Go
There were no statistically significant results for
the Timed up and Go among the three groups at 12 and
18- months (Table 6). At 12 and 18-months, Timed up
and Go scores (time in seconds) decreased in all three
groups when compared to baseline (Table 4). Timed up
and Go scores were lowest for all 3 groups at 12 months
when compared to 18 months. At 12 months, the WB
group had the lowest score 8.10 (±1.54) compared to the
other two groups. At 18 months, the self-directed (C)
group had the lowest score 7.88 (±1.89).
Level of physical activity
After participating in the 12-month walking program
[3-5], the WB group demonstrated the highest increase
in activity level (Table 7). Statistical significance was not
reached for “Leisure-Time Physical Activity” variables. At
12 months, the WB demonstrated the highest mean
scores for “Leisure-Time Physical Activity Walking only”
13.89 (±12.40) and for “Leisure-Time Physical Activity
Walking and other activities” 19.77 (±15.85). At 18
months, the self-directed (C) group demonstrated the
highest mean score of 16.88 (±17.50) for “Leisure-Time
Physical Activity Walking only” and 24.18 (±25.59) for
“Leisure-Time Physical Activity Walking & other activ-
ities”. At 12 and 18 months, the WB group had the high-
est mean score for “Occupational/Domestic Activity
Walking only” 33.00 (±70.75) and 33.07 (±39.04) and the
highest “Occupational/Domestic Activity Walking and
other activities” mean score 41.48 (±61.94). Statistical
significance was demonstrated for “Occupational/
Domestic Activity Walking and other activities” mean
scores at 12- months 27.99 (±37.28) and 18 months
26.13 (±15.64) for the WB group.Discussion
We attempted to find the best way to implement a
proven effective SCAWP from a clinical point of view
[3-5]. As expected from the Ottawa Panel CPG on
SCAWP [3-5], QOL as well as clinical outcomes of
this RCT improved among participants with mild to
moderate OA in each of the three comparative groups.
However, very few statistically significant differences
were observed for QOL and clinical outcomes over
a long duration after the 12-month intervention phase
and the 18-month follow-up phase. Results varied
among the three groups depending on which outcomes
were considered.
Participants from each group showed improvements in
QOL and clinical outcomes measurements as they bene-
fited from the walking component which has found be
effective according to the Ottawa Panel CPGs [3-5]. The
behavioural component facilitated the implementation of
The Ottawa Panel CPG on SCAWP [3-5] over a short-
term period (See part I), but did not have a direct impact
on QOL and clinical outcomes [6].Quality of life (QOL) outcomes
Various PA programs, including walking programs for
OA, have improved QOL when compared to a control
group with no walking involvement over a short-term
period [18-24]. However, this effect was not maintained
after a period of unsupervised PA at 6 months [24], 9
months [20], and 18 months [25]. This RCT used a self-
directed walking group as comparator.
Surprisingly, all statistically significant results favoured
the self-directed group (C) group compared to the two
walking groups (W and WB groups) with QOL improve-
ments at 12 and 18 months. The behavioural component
of the WB group was expected to improve participant
adherence to the program over a long period of time,
allowing participants to benefit from the proven effective
walking program by improving and maintaining QOL
and clinical outcomes. Some explanations as to why par-
ticipants in the self-directed (C) group demonstrated a
higher QOL score may be due to the development of
fewer health problems and fewer difficulties with trans-
portation resulting in less attrition to the study.
In addition, participants in the self-directed (C) group
may not have experienced as many barriers as the
other two groups in order to engage in walking activities
for at least 3 times a week. This group had the comfort
of being around their own environment, especially
for those who were not retired and still working.
These facilitators may have contributed to the improve-
ment of the participants’ QOL compared to the other
groups which were required to travel regularly to the
walking club.
Table 4 Summary of 6-minute walking for three study arms (6 Minute Walk Test)
Baseline 12 Months 18 Months
W WB C W WB C W WB C
N N N N N N N N N
Mean ± SD Mean ± SD Mean ± SD Mean ± SD Mean ± SD Mean ± SD Mean ± SD Mean ± SD Mean ± SD
W Vs. C(P) WB Vs. C(P) WB Vs. W(P) W Vs. C(P) WB Vs. C(P) WB Vs. W(P)
6-min walk 79 68 74 44 41 40 42 39 35
456.45 ± 87.62 475.27 ± 90.77 490.89 ± 99.30 524.86 ± 106.52 509.41 ± 82.43 520.52 ± 115.14 492.91 ± 86.95 500.15 ± 77.46 540.35 ± 103.37
0.063 0.535 0.215 0.366 0.318 0.902
W: Walking only group; WB: Walking and Behavioural Group; C: Self-directed group (unsupervised/self-directed); N: number of subjects in each comparative group; SD: standard deviation; vs: versus; data is presented



















Table 5 Summary of Gait Speed for three study arms
Baseline 12 Months 18 Months
W WB C W WB H W WB C
N N N N N N N N N
Mean ± SD Mean ± SD Mean ± SD Mean ± SD Mean ± SD Mean ± SD Mean ± SD Mean ± SD Mean ± SD
W Vs. C(P) WB Vs. C(P) WB Vs. W(P) W Vs. C(P) WB Vs. C(P) WB Vs. W(P)
Gait Speed 79 68 74 44 41 40 42 39 35
1.268 ± 0.243 1.320 ± 0.252 1.364 ± 0.276 1.458 ± 0.296 1.415 ± 0.229 1.446 ± 0.320 1.369 ± 0.242 1.389 ± 0.215 1.501 ± 0.287
(0.063) (0.535) (0.215) (0.366) (0.318) (0.902)
W: Walking only group; WB: Walking and Behavioural Group; C: Self-directed group (unsupervised/self-directed); N: number of subjects in each comparative group;
SD: standard deviation; vs: versus; data is presented as mean (standard deviation); P: p-value (statistical significance); * Statistically significant.
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demonstrated the highest compliance rate for the first
three months (Part I), they did not exhibit the highest
QOL scores [6]. The self-directed (C) group contained
the highest dropout rate, leading one to wonder if only
participants with a higher QOL decided to adhere to
regular walking.
Clinical outcomes
The results of primary RCTs which served to develop
Ottawa Panel CPGs [3-5] revealed that 10–60 minute
aerobic walking programs for OA are proven effective to
reduce pain intensity [18,22,47,52,53,60-62], to reduce
morning stiffness [20] , to increase strength [55,63], to
improve walking endurance [52,64] , to better manage
stairs climbing [59,60,62], to increase the number of
steps performed per day [62], to build self-efficacy on
stairs and in walking [65], to improve functional status
[24,47,59,64-66] and contribute to enhance QOL
[20,24,47,52,67] when compared to a control group with
no involvement of walking.
The nature of the walking program involved in the
three comparative groups of this KT RCT demonstrated
no differences between groups. The results of
Evick et al. [47] revealed that a home-based exercise pro-
gram is as effective as a supervised facility-based walking
program for significantly improving pain relief, physicalTable 6 Summary of Timed Up and Go for three study arms
Baseline 12 M
W WB C W WB
N N N N N
Mean ± SD Mean ± SD Mean ± SD Mean ± SD Mean
W Vs. C(P) WB V
TUG 79 69 74 44 41
9.04 ± 2.72 8.58 ± 2.45 8.34 ± 3.28 8.12 ± 2.44 8.10 ±
(0.796) (0.770
W: Walking only group; WB: Walking and Behavioural Group; C: Self-directed group (
SD: standard deviation; vs: versus; data is presented as mean (standard deviation); pfunction, and quality of life at follow-up 3 months.
Talbot et al. [55] observed that a home-based walking
combined with education compared to education only
improved the number of steps walked per day, improved
the amount of time to climb stairs, and improved
strength after the 12 week intervention and at follow-up
3- months post-intervention. The combined walking and
education group also demonstrated improved pain relief
at follow-up 3-months post intervention. Similar to a
study by Minor et al. [20], the self-directed (C) group
which was home-based, demonstrated the greatest
improvements in clinical outcomes.
PA creates a motor evoked potential drop which
decreases the corticomotor excitability which
consequently reduces pain [68]. In a trial using rats,
exercise has been shown to reverse signs of neuropathic
pain and increase endogenous opioid content in
brainstem regions which are important for pain mo-
dulation [69,70]. Several PA programs, including
walking, have been shown to result in decreased pain in
the lower extremities in those suffering from OA
[18,20,22,47,53,67,71,72]. In these studies, the duration
of the programs varied between 2 and 6 months. The
study by Minor [20] demonstrated that the reduction in
pain persisted after completion of the supervised aerobic
walking program (3 and 9-month follow-up) if subjects
continued to engage in PA. In this RCT, knee painonths 18 Months
C W WB C
N N N N
± SD Mean ± SD Mean ± SD Mean ± SD Mean ± SD
s. C(P) WB Vs. W(P) W Vs. C(P) WB Vs. C(P) WB Vs. W(P)
41 42 39 35
1.54 7.65 ± 1.79 8.41 ± 2.05 8.40 ± 1.36 7.88 ± 1.89
) (0.576) (0.860) (0.434) (0.525)
unsupervised/self-directed); N: number of subjects in each comparative group;
: p-value (statistical significance); * Statistically significant TUG: timed up and go.
Table 7 Summary of 7 day Physical Activity Recall for three study arms
Variables Baseline 12Months 18Month
W WB C W WB C W WB C
N N N N N N N N N
Mean ± SD Mean ± SD Mean ± SD Mean ± SD Mean ± SD Mean ± SD Mean ± SD Mean ± SD Mean ± SD
W Vs. C(P) WB Vs. C(P) WB Vs. W(P) W Vs. C(P) WB Vs. C(P) WB Vs. W(P)
LTA Walking
Only
63 49 56 42 37 38 40 33 32
12.09 ± 13.09 13.92 ± 16.50 12.45 ± 14.96 12.22 ± 7.86 13.89 ± 12.40 12.68 ± 11.20 12.20 ± 9.90 16.40 ± 18.72 16.88 ± 17.50
(0.816) (0.816) (0.987) (0.261) (0.932) (0.303)
LTA Walking
+Other
69 61 62 43 38 41 41 35 33
16.18 ± 21.49 16.43 ± 18.86 19.74 ± 22.87 15.34 ± 10.23 19.77 ± 15.85 16.01 ± 14.14 16.46 ± 13.17 22.15 ± 21.21 24.18 ± 25.59
(0.633) (0.139) (0.294) (0.404) (0.602) (0.165)
ODA Walking
Only
35 28 34 9 11 13 17 14 8
20.75 ± 25.69 11.92 ± 12.42 18.17 ± 25.98 17.10 ± 21.03 33.00 ± 70.75 11.05 ± 8.39 22.33 ± 26.10 33.07 ± 39.04 12.04 ± 5.64
(0.675) *(0.040) (0.113) (0.601) (0.076) (0.140)
ODA Walking
+Other
60 47 55 26 24 30 29 24 19
31.31 ± 36.00 19.77 ± 25.61 26.85 ± 30.88 22.63 ± 20.97 41.48 ± 61.94 27.99 ± 37.28 23.34 ± 22.40 27.97 ± 33.15 26.13 ± 15.64
(0.273) *(0.047) *(0.003) (0.198) (0.331) *(0.021)
W :Walking only group; WB: Walking and Behavioural Group; C: Self-directed group (unsupervised/self-directed); N: number of subjects in each comparative group;
SD: standard deviation; vs: versus; data is presented as mean (standard deviation); p: p-value (statistical significance); * Statistically significant; ODA: Other
domestic activities; LTA: Leisure time activities.
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http://www.biomedcentral.com/1471-2458/12/1073reduction, decreased morning stiffness and improved
functional status were observed in all three comparative
groups.
Surprisingly, there were no statistically significant
results for “Leisure-Time Physical Activity” compared to
“Occupational/Domestic Activity”. One reason for these
results may be that long term goal setting, included in
the Pace-ex program for those in the WB group, were
not based solely on walking activities and included any
daily activities (e.g. weight loss). The two other compara-
tive groups did not contain a goal setting intervention.
In addition, baseline results illustrated that participants
in the self-directed (C) group received a higher level of
education. Strong associations have been found between
level of education, physical fitness level, and amount of
leisure activity.Limitations
A major limitation of this study was the high attrition
rate in each implementation and dissemination groups.
As a result, validity of long-term results at 12-months
end of intervention and at 18-months follow-up is ques-
tionable. Participants in the self-directed (C) group had
initial lower values (poorer QOL) while participants in
WB group demonstrated higher baseline values (higher
QOL) for the physical components of the SF-36 and
AIMS2 questionnaires. This situation may have lead to a
potential bottom effect, creating larger room for QOL
(SF-36) improvements for the self-directed (C) groupand a potential ceiling effect for the WB group, resulting
in smaller incremental improvements for QOL.
The use of the AIMS2 questionnaire among this spe-
cific population is debatable. The study subjects enrolled
in this RCT were quite functional according to our
inclusion criteria. They had to experience a low level
degree of pain intensity and must have been able to walk
for more than 20 minutes consecutively. AIMS2 is a
QOL measurement designed for individuals with more
severe physical conditions. This may have led to a poten-
tial ceiling effect on certain sub-scales such as the phys-
ical components.
Another limitation may have been the nature of the
self-directed (C) group. The intervention among this
group consisted solely of the use of a pamphlet on walk-
ing. As a result, the self-directed (C) group was not an
inactive group, and walked regularly according to their
self-reported logbook reports. We believe that the self-
directed group (C) benefited just as much as the other
two groups from the positive effects of walking.
Lastly, there were missing data from the 7-day PAR
questionnaire as not all participants completed their log-
books and had difficulties remembering which activities
were performed, resulting in a potential recall bias.
Implications
This RCT was a long-term KT as well as compliance
study which addressed questions of clinical and scientific
importance. This study was designed to improve the
understanding of efficacy of KT strategies to promote
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proven effective walking program for OA in order to
improve the QOL of participants. Results of this study
revealed that a community-based location or home-
based walking program may be an effective strategy to
manage OA of the knee.
Conclusions
The three walking groups demonstrated globally equiva-
lent results for the implementation of KT strategies to
improve QOL and clinical outcomes over a long-term
period (12 and 18-months).
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